Fig. 1From: N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarctionArea under the receiver operating characteristic curve of the C-ACS and Bio-C-CACS-RS group for predicting in-hospital mortality (a) and major clinical adverse events (b)Back to article page